Syndax Pharmaceuticals Salaries & Compensation
Tech
Syndax Pharmaceuticals is a biopharmaceutical company focused on developing cancer therapies. Its lead products include SNDX-5613 for KMT2Ar and NPM1 acute myeloid leukemia, and SNDX-6352 for chronic graft versus host disease. The company is also developing Entinostat and has a licensing agreement with Eddingpharm International. Syndax Pharmaceuticals was founded in 2005 and is based in Waltham, Massachusetts.
Headquarters:Waltham, United States
Founded:2005
Employees:51-200
Type:public
Est. Revenue:$10M-$50M
Headquarters
No salary data for Syndax Pharmaceuticals yet.
Be the first to submit